The invention is related to a formulation comprising of a polyclonal IgY antibodies of SARS CoV2-and a pharmaceutical acceptable carrier, wherein the polyclonal IgY antibodies is in the range of 50- 200 mg (w/v) and wherein the polyclonal IgY antibodies is a lyophilised powder. The formulation is one of nasal spray ...
A BIO-FEED FORMULATION AND A METHOD FOR WHITE SPOT SYNDROME IN SHRIMPS
The present disclosure discloses a feed formulation for preventing and treating the white spot syndrome virus (WSSV) infection in crustaceans comprising of polyclonal IgY antibody formulation and crustacean feed; wherein the polyclonal IgY ant...